ArticleJournal of medical virology2024

One-Pot Assay Based on CRISPR/Cas13a Technology for HEV RNA Point-of-Care Testing.

Zihao Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.